Soleno Therapeutics, Inc. (SLNO) Earnings Call Analysis
NASDAQ · Unknown · Unknown
20/25
Growth 5
Margin 5
Expansion 3
Platform 3
Financial 4
latest quarter score
Earnings Reports
- 20
- 17
- 16